These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20095867)

  • 21. Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury.
    Ratan RR; Siddiq A; Aminova L; Langley B; McConoughey S; Karpisheva K; Lee HH; Carmichael T; Kornblum H; Coppola G; Geschwind DH; Hoke A; Smirnova N; Rink C; Roy S; Sen C; Beattie MS; Hart RP; Grumet M; Sun D; Freeman RS; Semenza GL; Gazaryan I
    Ann N Y Acad Sci; 2008 Dec; 1147():383-94. PubMed ID: 19076458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators.
    Amit T; Avramovich-Tirosh Y; Youdim MB; Mandel S
    FASEB J; 2008 May; 22(5):1296-305. PubMed ID: 18048580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIF-prolyl hydroxylases and cardiovascular diseases.
    Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
    Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of iron-chelators on ion-channels and HIF-1alpha in the carotid body.
    Roy A; Li J; Baby SM; Mokashi A; Buerk DG; Lahiri S
    Respir Physiol Neurobiol; 2004 Jul; 141(2):115-23. PubMed ID: 15239962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders.
    Mandel S; Amit T; Reznichenko L; Weinreb O; Youdim MB
    Mol Nutr Food Res; 2006 Feb; 50(2):229-34. PubMed ID: 16470637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NADPH oxidase-mitochondria axis-derived ROS mediate arsenite-induced HIF-1α stabilization by inhibiting prolyl hydroxylases activity.
    Li YN; Xi MM; Guo Y; Hai CX; Yang WL; Qin XJ
    Toxicol Lett; 2014 Jan; 224(2):165-74. PubMed ID: 24188932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactoferrin from bovine colostrum regulates prolyl hydroxylase 2 activity and prevents prion protein-mediated neuronal cell damage via cellular prion protein.
    Park YG; Moon JH; Park SY
    Neuroscience; 2014 Aug; 274():187-97. PubMed ID: 24875174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in iron chelation: an update.
    Heli H; Mirtorabi S; Karimian K
    Expert Opin Ther Pat; 2011 Jun; 21(6):819-56. PubMed ID: 21449664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal deferoxamine attenuates synapse loss via up-regulating the P38/HIF-1α pathway on the brain of APP/PS1 transgenic mice.
    Guo C; Zhang YX; Wang T; Zhong ML; Yang ZH; Hao LJ; Chai R; Zhang S
    Front Aging Neurosci; 2015; 7():104. PubMed ID: 26082716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-inducible factor-1 (HIF-1).
    Ke Q; Costa M
    Mol Pharmacol; 2006 Nov; 70(5):1469-80. PubMed ID: 16887934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain.
    Kupershmidt L; Weinreb O; Amit T; Mandel S; Bar-Am O; Youdim MB
    Neuroscience; 2011 Aug; 189():345-58. PubMed ID: 21570450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential application of iron chelators for the treatment of neurodegenerative diseases.
    Hider RC; Roy S; Ma YM; Le Kong X; Preston J
    Metallomics; 2011 Mar; 3(3):239-49. PubMed ID: 21344071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic applications of chelating drugs in iron metabolic disorders of the brain and retina.
    Shahandeh A; Bui BV; Finkelstein DI; Nguyen CTO
    J Neurosci Res; 2020 Oct; 98(10):1889-1904. PubMed ID: 32643793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-Methoxyestradiol confers neuroprotection and inhibits a maladaptive HIF-1α response after traumatic brain injury in mice.
    Schaible EV; Windschügl J; Bobkiewicz W; Kaburov Y; Dangel L; Krämer T; Huang C; Sebastiani A; Luh C; Werner C; Engelhard K; Thal SC; Schäfer MK
    J Neurochem; 2014 Jun; 129(6):940-54. PubMed ID: 24606183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of iron in brain ageing and neurodegenerative disorders.
    Ward RJ; Zucca FA; Duyn JH; Crichton RR; Zecca L
    Lancet Neurol; 2014 Oct; 13(10):1045-60. PubMed ID: 25231526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of reactive oxygen species in the regulation of HIF-1 by prolyl hydroxylase 2 under mild hypoxia.
    Niecknig H; Tug S; Reyes BD; Kirsch M; Fandrey J; Berchner-Pfannschmidt U
    Free Radic Res; 2012 Jun; 46(6):705-17. PubMed ID: 22360728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases.
    Singh YP; Pandey A; Vishwakarma S; Modi G
    Mol Divers; 2019 May; 23(2):509-526. PubMed ID: 30293116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron chelating strategies in systemic metal overload, neurodegeneration and cancer.
    Gumienna-Kontecka E; Pyrkosz-Bulska M; Szebesczyk A; Ostrowska M
    Curr Med Chem; 2014; 21(33):3741-67. PubMed ID: 25005181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anemia and cerebral outcomes: many questions, fewer answers.
    Hare GM; Tsui AK; McLaren AT; Ragoonanan TE; Yu J; Mazer CD
    Anesth Analg; 2008 Oct; 107(4):1356-70. PubMed ID: 18806052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxynitrite as an alternative donor of oxygen in HIF-1alpha proline hydroxylation under low oxygen availability.
    Sumbayev VV; Yasinska IM
    Free Radic Res; 2006 Jun; 40(6):631-5. PubMed ID: 16753841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.